Patents by Inventor Charles Scally

Charles Scally has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090215738
    Abstract: Disclosed is a is a treatment for the adverse psychological effects (including depression, low self esteem, guilt, increased stress, anhedonia, decreased cognition, sleep disturbances, general fatigue, agitation/motor dyskinesia and decreased appetite) resulting from androgens or GnRH analogue intake, by administering a compound which antagonizes estradiol or its receptors, or blocks and prevents estradiol binding to the estradiol receptors (including antiestrogens) and/or a compound which inhibits endogenous production of estradiol, including aromatase inhibitors. Suitable antiestrogens include clomiphene and its isomer enclomiphene, tamoxifen, 4-hydroxytamoxifen, and toremifene. Suitable cytochrome P450 (P450arom) aromatase inhibitors include formestane, exemestane, anastrozole, and letrozole.
    Type: Application
    Filed: February 24, 2009
    Publication date: August 27, 2009
    Inventor: Michael Charles Scally
  • Publication number: 20090215733
    Abstract: Methods of treating or reducing the risk of one or more effects or signs of induced hypogonadism after androgen or GnRH intake are disclosed herein. In an embodiment, a method of treating one or more effects after androgen or gonadotropin releasing hormone (GnRH) analogue intake comprises administering to a male subject at least one of a blocking compound which antagonizes estradiol binding to estradiol receptors or an inhibitor compound which inhibits endogenous production of estradiol, after androgen or gonadotropin releasing hormone (GnRH) analogue intake, to treat the one or more effects. The one or more effects include adverse body composition changes, decreased muscle strength, or both. The inhibitor compound and/or blocking compound may include antiestrogen agents, aromatase inhibitors, or combinations thereof.
    Type: Application
    Filed: February 24, 2009
    Publication date: August 27, 2009
    Inventor: Michael Charles Scally
  • Patent number: 6113160
    Abstract: A latch secures a first member such as a door panel against a second member such as a corresponding frame. The latch comprises a housing for mounting in the first member, a pawl adapted for engaging a keeper in a latched position on the second member and latch actuating means for selectively moving the pawl into a position away from the keeper in order to allow the first member to be opened.
    Type: Grant
    Filed: March 9, 1998
    Date of Patent: September 5, 2000
    Assignee: Southco, Inc.
    Inventors: Torsten Johansson, Claes Magnusson, Glenn Anderson, Charles Scally, J. Michael Wittig, Stefan Koveal, James H. Vickers